Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP – Get Free Report) have earned an average recommendation of “Moderate Buy” from the six ratings firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $19.17.
CCAP has been the subject of several research analyst reports. Keefe, Bruyette & Woods raised their price target on Crescent Capital BDC from $19.00 to $20.00 and gave the company an “outperform” rating in a report on Monday, November 25th. LADENBURG THALM/SH SH started coverage on Crescent Capital BDC in a research report on Monday, September 30th. They set a “buy” rating and a $20.00 target price for the company.
Get Our Latest Stock Analysis on Crescent Capital BDC
Crescent Capital BDC Trading Down 1.7 %
Crescent Capital BDC Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 31st will be issued a $0.42 dividend. This represents a $1.68 annualized dividend and a dividend yield of 8.74%. The ex-dividend date is Tuesday, December 31st. This is a positive change from Crescent Capital BDC’s previous quarterly dividend of $0.07. Crescent Capital BDC’s dividend payout ratio (DPR) is 65.88%.
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of CCAP. Franklin Resources Inc. increased its stake in Crescent Capital BDC by 35.2% in the 3rd quarter. Franklin Resources Inc. now owns 256,279 shares of the company’s stock worth $4,726,000 after buying an additional 66,713 shares during the period. Kovitz Investment Group Partners LLC bought a new stake in shares of Crescent Capital BDC during the third quarter valued at approximately $4,878,000. Stifel Financial Corp boosted its holdings in shares of Crescent Capital BDC by 53.1% in the third quarter. Stifel Financial Corp now owns 66,470 shares of the company’s stock valued at $1,230,000 after purchasing an additional 23,055 shares during the period. HighTower Advisors LLC grew its stake in Crescent Capital BDC by 0.5% in the third quarter. HighTower Advisors LLC now owns 141,838 shares of the company’s stock worth $2,624,000 after purchasing an additional 768 shares in the last quarter. Finally, Confluence Investment Management LLC increased its holdings in Crescent Capital BDC by 2.2% during the 3rd quarter. Confluence Investment Management LLC now owns 73,206 shares of the company’s stock worth $1,354,000 after purchasing an additional 1,583 shares during the period. Institutional investors own 49.46% of the company’s stock.
About Crescent Capital BDC
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Featured Stories
- Five stocks we like better than Crescent Capital BDC
- What Are Treasury Bonds?
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- What Are Dividend Contenders? Investing in Dividend Contenders
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.